PLAU and breast carcinoma: Indeed, two of thebest-validated prognostic indicators (level of evidence [LOE] = 1) in breastcarcinoma are the serine protease urokinase plasminogen activator (uPA) and itsendogenous inhibitor PAI-1 [38].